William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Accern Successfully Completes SOC 2 Type 2 Examination
-
myDigitalOffice Receives Strategic Investment From Cove Hill Partners
-
Despite Prior Hiccups, Revance Therapeutic (RVNC) Could Launch DAXlin in Early 2023 - William Blair
-
Arsenal Acquires Automation Solutions Provider Eckhart from LFM Capital
-
UPDATE: William Blair Upgrades Snowflake Inc. (SNOW) to Outperform
-
Arcellx (ACLX) Files IPO Registration Statement
-
Holding(s) in Company
-
GoEngineer Completes Recapitalization with Court Square Capital Partners
-
William Blair Experiences Record Growth, Elects Brent Gledhill CEO
-
Form N-CEN WILLIAM BLAIR FUNDS For: Oct 31
-
Pre-Open Stock Movers 01/12: (OCGN) (RKLB) (NXPI) Higher; (BIIB) (CCOI) (RC) Lower (more...)
-
LINQ Announces Strategic Growth Investment from Welsh, Carson, Anderson & Stowe
-
UPDATE: William Blair Upgrades Shopify (SHOP) to Outperform
-
Lightspeed Systems® Expands Digital Learning Offering with Acquisition of CatchOn
-
Levine Leichtman Capital Partners Sells HomeVestors of America
-
Arlington Capital Partners Announces the Acquisition of Millstone Medical Outsourcing
-
Sarepta Therapeutics' (SRPT) Now Has Clear Path for SRP-9001's Regulatory Submission; Gene Therapy Pipeline Will Generate Up to $800M in 2022 - William Blair
-
Sparsentan Is Main Driver of Travere Therapeutics (TVTX) Stock, Progress On the Drug is Encouraging, Product Should Ultimately be Approved - William Blair
-
Street Bullish on Samsara (IOT), Sees Rapid Growth Ahead
-
AlphaSense Adds William Blair as Latest Contributor to Wall Street Insights® (WSI)
-
UPDATE: William Blair Starts Cvent (CVT) at Outperform
-
UPDATE: William Blair Starts Samsara Inc (IOT) at Outperform
-
Atea Pharmaceuticals' (AVIR) Continues to Have a Significant Market in COVID Response, Despite Data Setbacks - William Blair
-
UPDATE: William Blair Starts The Beauty Health Company (SKIN) at Outperform
-
Latham Group, Inc. Announces Pricing of Public Offering of Shares of its Common Stock
-
Latham Group, Inc. Announces Pricing of Public Offering of Shares of its Common Stock
-
William Blair Downgrades Vocera Communications (VCRA) to Market Perform, Following Acquisition
-
Scott McLaughlin Joins William Blair as Head of Equities
-
Oxford Lane Capital Corp. Prices Public Offering of $87 Million 5.00% Notes Due 2027
-
Bionomics Limited Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs in the United States
-
Form 40-17G WILLIAM BLAIR FUNDS
-
Castlight Health (CSLT) and Vera Whole Health to Combine
-
Castlight Health and Vera Whole Health to Combine to Pioneer and Scale Value-Based Care in Commercial Market
-
Smile Doctors Receives Strategic Investment from Thomas H. Lee Partners
-
WindRose Health Investors Invests in Terrapin Pharmacy
-
Galderma Successfully Completes Acquisition of ALASTIN Skincare®
-
7 Things to Know About the Upcoming $1.9 Billion IPO for Justworks, Inc. (JW)
-
Oxford Lane Capital Corp. Announces Offering of Notes
-
Corsair Acquires Majority Stake in Aurora Payments
-
Justworks, Inc (JW) Launches 7M Share IPO
-
Justworks Announces Launch of Initial Public Offering
-
Levine Leichtman Capital Partners Sells West Academic
-
UPDATE: William Blair Starts HashiCorp Inc (HCP) at Outperform
-
Martis Capital Announces Investment Team Promotions
-
Reverence Capital Partners Makes Majority Investment in Ministry Brands
-
Form N-CSR WILLIAM BLAIR FUNDS For: Oct 31
-
Sachem Capital Corp. Announces Sale of an Additional of $6.75 Million of 6.0% Notes Due 2026 from Exercise of Over Allotment Option
-
XBI Will Rebound, COVID Will Ease, Gene Therapy Approvals to Triple, Focus on NASH to Return - William Blair Biotech Predictions for 2022
-
Form 485APOS WILLIAM BLAIR FUNDS
-
Flexpoint Ford Expands Senior Investment Team with Promotions to Managing Director and Principal

